USPTO serial 79434997
AMCAP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GANESH, HARINI
- Law office
- TMO LAW OFFICE 122
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with AMCAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical drugs; medicines; chemical preparations for pharmaceutical purposes; biological preparations for medical purposes; chemico-pharmaceutical preparations; biological reagents for medical purposes; vaccines; nucleic acid-based pharmaceutical and veterinary products; food and dietary substances for medical or veterinary use; therapeutic antibodies; dietary supplements and preparations; pharmaceutical and natural medicines; nucleic acid-based preparations; cell-based preparations; tissue-based preparations; biological preparations; biological preparations for medical and pharmaceutical use; diagnostic preparations; engineered biological tissues for medical purposes; sanitary preparations for medical purposes; advanced therapy medicinal products; personalized medicine products; regenerative medicine products; somatic cell therapy products; gene therapy products; recombinant human protein being biochemical preparations and nucleic acid sequences for medical use. | ACTIVE | — |
| 042 | Research and development of vaccines and nucleic acid-based medicines; scientific and technological services; research services in the medical and pharmaceutical fields; development of pharmaceutical preparations and medicines; development of pharmaceutical reagents and medicines; providing information and data relating to medical and veterinary research and development; medical laboratories; design and development of hardware and software; research and development in the biochemical and nucleic acid fields; research and development services in the field of microorganisms and cells; research and development services in the field of diagnostic preparations; research and development in the pharmaceutical and biotechnological sector; research and development services for the pharmaceutical industry; scientific research in the biological field; research on medicines; research on reagents; medical research laboratory services; research services for the development of new pharmaceutical products and advanced therapies; development of biological drugs and advanced therapies; biological and chemical analysis in the medical and pharmaceutical fields. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 20, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 10, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 9, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |